Micro-X Ltd. (AU:MX1)
ASX:MX1
Want to see AU:MX1 full AI Analyst Report?
MX1 Stock Chart & Stats
AU$0.10
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.10
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.12
Previous CloseN/A
Volume191.73K
Average Volume (3M)189.28K
Market Cap
AU$33.54M
Enterprise ValueAU$34.50M
Total Cash (Recent Filing)AU$4.90M
Total Debt (Recent Filing)AU$5.13M
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding729,189,450
10 Day Avg. Volume131,613
30 Day Avg. Volume189,275
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)3.96
Price to Sales (P/S)2.29
P/FCF Ratio-3.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.15Price Target Upside50.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$26.90M
Bulls Say, Bears Say
Bulls Say
Proprietary X‑ray TechnologyMicro‑X's carbon nanotube cold cathode X‑ray tube is a durable technological moat that enables compact, lightweight, field‑deployable systems. This IP differentiates products, raises entry barriers, and supports long‑term product roadmaps in medical and defence markets.
High Gross MarginA 79% gross margin indicates strong unit economics and pricing power at the product level. If Micro‑X controls operating costs and scales revenue, this margin can translate into sustainable operating leverage and improved profitability over the medium term.
Multiple End MarketsServing both medical and security/defence markets diversifies addressable demand and procurement channels. This reduces customer concentration risk and creates multiple long‑duration revenue streams tied to secular trends in mobile imaging and security screening.
Bears Say
Declining Revenue & LossesRecent revenue decline and persistent net losses indicate the company is not yet converting product advantage into growing sales and profits. Continued revenue weakness undermines scaling, heightens funding needs, and delays sustainable margin realization over the coming months.
Negative Cash FlowsNegative operating and free cash flows constrain the firm's ability to fund R&D, production ramp and after‑sales support internally. Reliance on external financing increases, which can be dilutive or costly and limit strategic flexibility over a multi‑month horizon.
Rising Leverage & Negative ROEHigher debt levels combined with negative ROE raise financial risk and interest burden. This reduces balance sheet resilience and may limit investment capacity or force expensive financing unless profitability and cash generation materially improve.
Micro-X Ltd. News
MX1 FAQ
What was Micro-X Ltd.’s price range in the past 12 months?
Micro-X Ltd. lowest share price was AU$0.04 and its highest was AU$0.12 in the past 12 months.
What is Micro-X Ltd.’s market cap?
Micro-X Ltd.’s market cap is AU$33.54M.
When is Micro-X Ltd.’s upcoming earnings report date?
Micro-X Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 100 days.
How were Micro-X Ltd.’s earnings last quarter?
Micro-X Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of -AU$0.006 by -AU$0.004.
Is Micro-X Ltd. overvalued?
According to Wall Street analysts Micro-X Ltd.’s price is currently Undervalued.
Does Micro-X Ltd. pay dividends?
Micro-X Ltd. does not currently pay dividends.
What is Micro-X Ltd.’s EPS estimate?
Micro-X Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Micro-X Ltd. have?
Micro-X Ltd. has 729,189,450 shares outstanding.
What happened to Micro-X Ltd.’s price movement after its last earnings report?
Micro-X Ltd. reported an EPS of -AU$0.01 in its last earnings report, missing expectations of -AU$0.006. Following the earnings report the stock price went up 15.385%.
Which hedge fund is a major shareholder of Micro-X Ltd.?
Currently, no hedge funds are holding shares in AU:MX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Micro-X Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.15 (50.00% Upside)
AU$0.15 (50.00% Upside)
Blogger Sentiment
Bullish
AU:MX1 Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$200.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.40%
12-Months-Change
Fundamentals
Return on Equity
-180.06%
Trailing 12-Months
Asset Growth
-12.76%
Trailing 12-Months
Company Description
Micro-X Ltd.
Micro-X Limited designs, develops, and manufactures lightweight carbon nano tube-based X-ray products for the healthcare and security imaging markets in Australia. The company offers rover veterinary, a mobile X-ray machine to diagnose and treat animals for general veterinarian practices; Carestream DRX Revolution Nano, a mobile X-ray imaging machine used for high intensity workflow diagnostic medical imaging in hospitals; and IED X-ray cameras. It also provides miniature baggage scanners to detect hidden threats concealed within passenger carry-on luggage; airport screening reimagined, a passenger self-screening airport checkpoint; and brain CT scanners for use in road and air ambulances. The company was incorporated in 2011 and is based in Tonsley, Australia.
MX1 Stock 12 Month Forecast
Average Price Target
AU$0.15
▲(50.00% Upside)
Technical Analysis
Cyclopharm Limited
―
CleanSpace Holdings Ltd.
―
EMvision Medical Devices Ltd.
―
Control Bionics Ltd.
―
4DMedical Ltd
―
Options Prices
Currently, No data available
---